Alebund Biotech Inc.

The week before the annual J.P. Morgan Healthcare Conference always brings a flurry of new venture capital financings and the tradition continued in 2025, including Aviceda Therapeutics with a $207.5m

Shares of Beijing Luzhu Biopharmaceutical Co Ltd (Luzhu Biotech) were listed on the Hong Kong Stock Exchange on 8 May, making the Chinese developer of vaccines and monoclonal and bispecific antibodi

Lightstone Ventures has closed its third fund – its largest to date – with $375m to fund early stage biopharmaceutical and medical technology companies after several successful exits via initial publi

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. GC Pharma, Speragen To Co-Develop SSADH